List of insiders holdings for Kairos Pharma LTD.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Yu John S CEO and Chairman 10% Owner | 2024-09-24 21:00:07 | 5,337,837 0 | 5,337,837 | Form 3 |
| Bhowmick Neil Chief Scientific Officer | 2024-09-24 21:00:14 | 1,125,983 0 | 1,125,983 | Form 3 |
| Murali Ramachandran VP of Research and Development | 2024-09-24 21:00:12 | 132,857 0 | 132,857 | Form 3 |
| Samuelson Doug Chief Financial Officer | 2024-09-24 21:00:09 | 58,296 0 | 58,296 | Form 3 |
| Bae Hyun W. Director | 2024-09-24 21:00:06 | 44,286 0 | 44,286 | Form 3 |
| MAZANET ROSEMARY Director | 2024-09-24 21:00:13 | 0 0 | 0 | Form 3 |
| Keyoung Hansoo Michael Director | 2024-09-24 21:00:10 | 0 0 | 0 | Form 3 |